Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
Journal Title: Turkish Journal of Hematology - Year 2019, Vol 36, Issue 2
Abstract
Objective: Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment modality for a variety of malignant and non-malignant hematologic disorders. Myeloablative conditioning (MAC) and reduced-intensity conditioning (RIC) regimens could have different clinical outcomes. This purpose of this study was to assess the long-term outcome of MAC versus RIC regimens in patients with acute myeloid leukemia (AML) undergoing allogeneic HSCT. Materials and Methods: We retrospectively compared long-term outcomes with MAC and RIC regimens in patients with AML who underwent allo-HSCT at our tertiary transplantation center. Results: We analyzed survival outcomes after MAC-HSCT versus RICHSCT among 107 adult patients with AML diagnosed from 2001 through 2017. Of those, 44 patients underwent a MAC regimen, whereas 63 patients received a RIC regimen. The median follow-up time was 37 months (range: 6-210) for the entire group. The 3-year overall survival (OS) for RIC and MAC patients was 67% and 60%, respectively (p>0.05). The 3-year progression-free survival (PFS) for RIC and MAC patients was 88% and 77%. In multivariate analysis, the type of conditioning regimen (RIC vs. MAC) did not influence PFS (p=0.24). Acute graft-versus-host disease (GVHD) was seen in five of the RIC patients and 9 of the MAC patients. Chronic GVHD was seen in 16 of the RIC patients and 6 of the MAC patients. There was no significant difference between the two groups in terms of acute GVHD (p=0.089), but there was a significant difference between the two groups in terms of chronic GVHD (p=0.03). Conclusion: This retrospective analysis confirmed that MAC and RIC regimens had a consistently equivalent rate of OS and PFS in AML patients who underwent allo-HSCT. The choice of MAC versus RIC conditioning regimen might be decided on the basis of patient and disease characteristics.
Authors and Affiliations
Rafiye Çiftçiler, Hakan Göker, Haluk Demiroğlu, Elifcan Aladağ, Salih Aksu, İbrahim Calalettin Haznedaroğlu, Nilgün Sayınalp, Osman Özcebe, Fatma Tekin, Yahya Büyükaşık
Keywords
Related Articles
- EP ID EP553122
- DOI 10.4274/tjh.galenos.2019.2018.0220
- Views 78
- Downloads 0
Dasatinib F317L BCR-ABL Mutasyonu Olan Kronik Miyeloid Lösemi Hastalarında Etkili Olabilir
Splenic Infarct in a Patient with Autoimmune Hemolytic Anemia
To the Editor, Splenic infarct may be observed during the course of several diseases; however, the incidence is quite low.Splenic infarct is related to thromboembolic events; various diseases, including sickle cell anem...
A Case of Cutaneous Diffuse Large B-cell Lymphoma
Are university students a favorable target group for blood donation campaigns?
Objective: The aim of this study was to investigate the willingness of university students regarding blood donation and to compare results among residents living in the Kayseri city center. Materials and Methods: Admis...
The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma
Objective: Angiotensin II promotes growth and angiogenesis via type 1 receptors (AGTR1) in certain tumors. In this study, we examine the bone marrow AGTR1 expression in multiple myeloma (MM) and its relationship with the...